Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Misael Uribe

Showing results (181-190 of 261) with videos related to

Pageof 27
Sort By:
Annals of Hepatology|February 21, 2012
Increased mortality from acute liver failure in MexicoNorberto C Chávez-Tapia, Tonatiuh Barrientos-Gutiérrez, Carlos Manuel Guerrero-López, et al.
International Journal of Molecular Sciences|April 27, 2024
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis SpectrumPaulina Vidal-Cevallos, Adriana P Sorroza-Martínez, Norberto C Chávez-Tapia, et al.
World Journal of Gastroenterology|May 29, 2008
Factors that influence outcome in non-invasive and invasive treatment in polycystic liver disease patientsJosue Barahona-Garrido, Jesus Camacho-Escobedo, Eduardo Cerda-Contreras, et al.
Journal of Hepatocellular Carcinoma|July 12, 2022
Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular CarcinomaNorberto C Chavez-Tapia, Sofía Murúa-Beltrán Gall, Ana Luisa Ordoñez-Vázquez, et al.
Annals of Hepatology|March 31, 2005
Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality dataNahum Méndez-Sánchez, Antonio R Villa, Norberto C Chávez-Tapia, et al.
World Journal of Gastroenterology|January 5, 2007
Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic reviewNorberto-C Chavez-Tapia, Tonatiuh Barrientos-Gutierrez, Felix-I Tellez-Avila, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 11, 2020
Cholecystectomy as a risk factor for non-alcoholic fatty liver disease developmentItzayana Rodríguez-Antonio, Guillermo N López-Sánchez, Victor Y Garrido-Camacho, et al.
Journal of Endocrinological Investigation|June 27, 2025
The pathophysiological link between type 1 diabetes and MASLD: insights into insulin resistance and liver dysfunctionJosé L Herrera-Ojeda, Ray S Blanco-Palma, Norberto C Chávez-Tapia, et al.
Annals of Hepatology|September 6, 2012
Clinical course and management of acute hepatitis A infection in adultsIleana Mackinney-Novelo, Josué Barahona-Garrido, Fátima Castillo-Albarran, et al.
World Journal of Gastroenterology|March 29, 2005
Adiponectin as a protective factor in hepatic steatosisNahum Mendez-Sanchez, Norberto-C Chavez-Tapia, Antonio-R Villa, et al.
Pageof 27

Showing results (181-190 of 261) with videos related to

Sort By:
Pageof 27
Annals of Hepatology|February 21, 2012
Increased mortality from acute liver failure in MexicoNorberto C Chávez-Tapia, Tonatiuh Barrientos-Gutiérrez, Carlos Manuel Guerrero-López, et al.
International Journal of Molecular Sciences|April 27, 2024
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis SpectrumPaulina Vidal-Cevallos, Adriana P Sorroza-Martínez, Norberto C Chávez-Tapia, et al.
World Journal of Gastroenterology|May 29, 2008
Factors that influence outcome in non-invasive and invasive treatment in polycystic liver disease patientsJosue Barahona-Garrido, Jesus Camacho-Escobedo, Eduardo Cerda-Contreras, et al.
Journal of Hepatocellular Carcinoma|July 12, 2022
Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular CarcinomaNorberto C Chavez-Tapia, Sofía Murúa-Beltrán Gall, Ana Luisa Ordoñez-Vázquez, et al.
Annals of Hepatology|March 31, 2005
Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality dataNahum Méndez-Sánchez, Antonio R Villa, Norberto C Chávez-Tapia, et al.
World Journal of Gastroenterology|January 5, 2007
Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic reviewNorberto-C Chavez-Tapia, Tonatiuh Barrientos-Gutierrez, Felix-I Tellez-Avila, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 11, 2020
Cholecystectomy as a risk factor for non-alcoholic fatty liver disease developmentItzayana Rodríguez-Antonio, Guillermo N López-Sánchez, Victor Y Garrido-Camacho, et al.
Journal of Endocrinological Investigation|June 27, 2025
The pathophysiological link between type 1 diabetes and MASLD: insights into insulin resistance and liver dysfunctionJosé L Herrera-Ojeda, Ray S Blanco-Palma, Norberto C Chávez-Tapia, et al.
Annals of Hepatology|September 6, 2012
Clinical course and management of acute hepatitis A infection in adultsIleana Mackinney-Novelo, Josué Barahona-Garrido, Fátima Castillo-Albarran, et al.
World Journal of Gastroenterology|March 29, 2005
Adiponectin as a protective factor in hepatic steatosisNahum Mendez-Sanchez, Norberto-C Chavez-Tapia, Antonio-R Villa, et al.
Pageof 27